| Literature DB >> 27357616 |
Abstract
Atherosclerosis, the primary cause of cardiovascular disease (CVD), is a chronic inflammatory disorder in the walls of medium and large arteries. CVD is currently responsible for about one in three global deaths and this is expected to rise in the future due to an increase in the prevalence of obesity and diabetes. Current therapies for atherosclerosis mainly modulate lipid homeostasis and while successful at reducing the risk of a CVD-related death, they are associated with considerable residual risk and various side effects. There is, therefore, a need for alternative therapies aimed at regulating inflammation in order to reduce atherogenesis. This review will highlight the key role cytokines play during disease progression as well as potential therapeutic strategies to target them.Entities:
Keywords: atherosclerosis; cardiovascular disease; chemokines; cytokines; foam cells; inflammation; nanoparticles; neutralization
Mesh:
Substances:
Year: 2016 PMID: 27357616 PMCID: PMC5382975 DOI: 10.4155/fmc-2016-0072
Source DB: PubMed Journal: Future Med Chem ISSN: 1756-8919 Impact factor: 3.808